BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27007444)

  • 1. New tools for experimental diabetes research: Cellular reprogramming and genome editing.
    Otonkoski T
    Ups J Med Sci; 2016 May; 121(2):146-50. PubMed ID: 27007444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome editing of human pancreatic beta cell models: problems, possibilities and outlook.
    Balboa D; Prasad RB; Groop L; Otonkoski T
    Diabetologia; 2019 Aug; 62(8):1329-1336. PubMed ID: 31161346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development.
    Millette K; Georgia S
    Curr Diab Rep; 2017 Oct; 17(11):116. PubMed ID: 28980194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?
    Gerace D; Martiniello-Wilks R; Nassif NT; Lal S; Steptoe R; Simpson AM
    Stem Cell Res Ther; 2017 Mar; 8(1):62. PubMed ID: 28279194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Pluripotent Stem Cells to Model Islet Defects in Diabetes.
    Balboa D; Iworima DG; Kieffer TJ
    Front Endocrinol (Lausanne); 2021; 12():642152. PubMed ID: 33828531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light-stimulated insulin secretion from pancreatic islet-like organoids derived from human pluripotent stem cells.
    Choi J; Shin E; Lee J; Devarasou S; Kim D; Shin JH; Choi JH; Heo WD; Han YM
    Mol Ther; 2023 May; 31(5):1480-1495. PubMed ID: 36932674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of pancreatic islet cells from human embryonic stem cells.
    Zhang D; Jiang W; Shi Y; Deng H
    Sci China C Life Sci; 2009 Jul; 52(7):615-21. PubMed ID: 19641866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pluripotent stem cell based islet models for diabetes research.
    Balboa D; Otonkoski T
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):899-909. PubMed ID: 26696518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
    Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
    Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell differentiation: therapeutical challenges in diabetes.
    Roche E; Vicente-Salar N; Arribas M; Paredes B
    J Stem Cells; 2012; 7(4):211-28. PubMed ID: 24196797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene editing advance re-ignites debate on the merits and risks of animal to human transplantation.
    Fung RK; Kerridge IH
    Intern Med J; 2016 Sep; 46(9):1017-22. PubMed ID: 27633468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes.
    Street CN; Sipione S; Helms L; Binette T; Rajotte RV; Bleackley RC; Korbutt GS
    Int J Biochem Cell Biol; 2004 Apr; 36(4):667-83. PubMed ID: 15010331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy.
    Kehler J; Greco M; Martino V; Pachiappan M; Yokoe H; Chen A; Yang M; Auerbach J; Jessee J; Gotte M; Milanesi L; Albertini A; Bellipanni G; Zucchi I; Reinbold RA; Giordano A
    J Cell Physiol; 2017 Jun; 232(6):1262-1269. PubMed ID: 27631155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pluripotent stem cells.
    Carpenedo RL; Julian LM; Stanford WL
    Methods; 2016 May; 101():1-3. PubMed ID: 27090006
    [No Abstract]   [Full Text] [Related]  

  • 19. Human Pluripotent Stem Cells Go Diabetic: A Glimpse on Monogenic Variants.
    Heller S; Melzer MK; Azoitei N; Julier C; Kleger A
    Front Endocrinol (Lausanne); 2021; 12():648284. PubMed ID: 34079523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological characteristics and identification of islet-like cells derived from rat adipose-derived stem cells cocultured with pancreas adult stem cells.
    Hefei W; Yu R; Haiqing W; Xiao W; Jingyuan W; Dongjun L
    Cell Biol Int; 2015 Mar; 39(3):253-63. PubMed ID: 25262665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.